EMA (EU)
EVENT
Q&A clinic on Substance, Organisation, Referentials Management Services - July 2026
Published: 7/8/2026Detected: 6/30/2026
Summary preview
Provides an EMA Q&A session for companies on how to handle Substance, Organisation and Referentials (S,O,R) management services, including expected interactions with EMA regulatory data management processes.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountquality
clinical
safety
labeling
manufacturing
#EMA
#regulatory data management
#SPOR master data
#XEVMPD
#Product Management Service (PMS)
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026